Atwood & Palmer Inc. increased its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 113,077 shares of the medical research company’s stock after acquiring an additional 220 shares during the quarter. Thermo Fisher Scientific comprises about 3.1% of Atwood & Palmer Inc.’s investment portfolio, making the stock its 10th largest position. Atwood & Palmer Inc.’s holdings in Thermo Fisher Scientific were worth $19,728,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Proficio Capital Partners LLC lifted its stake in shares of Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after acquiring an additional 253 shares during the period. Chicago Partners Investment Group LLC acquired a new position in shares of Thermo Fisher Scientific during the second quarter valued at $108,000. Cribstone Capital Management LLC lifted its stake in shares of Thermo Fisher Scientific by 8.7% during the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 50 shares during the period. Sharkey Howes & Javer lifted its stake in shares of Thermo Fisher Scientific by 1.0% during the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after acquiring an additional 7 shares during the period. Finally, Shine Investment Advisory Services Inc. acquired a new position in shares of Thermo Fisher Scientific during the second quarter valued at $113,000. 83.36% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/atwood-palmer-inc-purchases-220-shares-of-thermo-fisher-scientific-inc-tmo/1614398.html.

In other news, VP Seth H. Hoogasian sold 4,140 shares of the business’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $177.80, for a total value of $736,092.00. Following the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 1,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the transaction, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders sold a total of 52,738 shares of company stock worth $9,302,112 over the last three months. 0.49% of the stock is owned by company insiders.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 193.21 on Friday. The firm has a market cap of $75.37 billion, a price-to-earnings ratio of 33.66 and a beta of 1.05. The stock’s 50 day moving average price is $186.68 and its 200-day moving average price is $173.88. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.03 EPS. On average, analysts forecast that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.45%.

Several equities analysts have recently issued reports on TMO shares. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target on the stock in a research note on Thursday, September 21st. Bank of America Corporation reissued a “buy” rating and issued a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Cowen and Company reissued an “outperform” rating and issued a $220.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Sunday, September 10th. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Barclays PLC reissued an “overweight” rating and issued a $215.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. One research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $202.21.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.